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The role of cytosolic free Ca2+ in insulin release was evaluated using isolated rat pancreatic islets permeabi- 
lized with digitonin and incubated in Ca-EGTA buffers to fix free Caz+ concentration at arbitrary levels. 
Caz+ induced insulin release in a concentration-dependent manner with the threshold being between 0.1 and 
1 PM. The hormone release was increased by forskolin and 120tetradecanoyl phorbol-13-acetate (TPA), 
a potent activator of adenylate cyclase and that of protein kinase C, respectively. The findings suggest that 
activation of both protein kinase A and protein kinase C modulate insulin release without a concomitant 
increase in cytosolic free Caz+. 
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1. INTRODUCTION 
It has been widely accepted, mainly based on 
45Ca2+ flux studies, that all initiators or poten- 
tiators for insulin release exert their effects 
through a common mechanism, i.e., increasing 
cytosolic free calcium concentration ([Ca’+]i) [I]. 
The view was also supported by the data obtained 
with the recent introduction of fluorescent Ca’+ in- 
dicators into pancreatic B cells [2-41. However, 
the latest measurements of [Ca2+]i with the in- 
dicator showed that forskolin, a potent activator 
of adenylate cyclase, evoked insulin release 
without a rise in [Ca2+]i [5]. Thus, the role of 
cytosolic free Ca2+ as an intracellular messenger 
for insulin release is still a matter of controversy. 
Taking another experimental approach, we have 
attempted to clarify whether insulin release can be 
evoked independently of a rise in [Ca’+]i. To avoid 
changes of [Ca’+]i on stimulation, we permeabil- 
ized rat pancreatic islets with digitonin and in- 
cubated them in Ca-EGTA buffers. Under these 
conditions, insulin release was increased by for- 
skolin and 12-0-tetradecanoyl phorbol-13-acetate 
(TPA), a potent activator of protein kinase C. 
Forskolin Phorbol ester Cytosolic free Ca2+ 
2. EXPERIMENTAL 
Islets were isolated from pancreases of fed male 
Wistar rats by collagenase digestion, and prein- 
cubated for 1 h in Krebs-Ringer bicarbonate buf- 
fer containing 3 mM glucose and 5 mg/ml bovine 
serum albumin. Then, they were treated with 
digitonin (25 /cg/ml) (Sigma, St Louis, MO) for 
5 min according to the method used in adrenal 
medullary cells [6]. After washing 3 times, groups 
of 5 islets were incubated at 37°C for 30 min in the 
media with various concentrations of Ca2+ and test 
substances. The composition of the media for 
digitonin treatment and incubation (mM): K- 
glutamate, 100; Na-glutamate, 42; Mg-ATP, 1; 
Hepes, 16; glucose, 3; EGTA, 1; and bovine serum 
albumin (5 mg/ml). CaC12 was added appropriate- 
ly and the pH was adjusted to 7.0 with NaOH. Us- 
ing stability constants of EGTA [7], concentra- 
tions of free Ca2+ in the presence of the chelator 
were kindly computed by Dr A. Takai, Depart- 
ment of Physiology, University of Nagoya, Japan. 
Forskolin (Calbiochem, La Jolla, CA) was added 
to the incubation media from stock solution 
(20 mM) prepared in 95% ethanol, and TPA 
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(Sigma) was from that (162 PM) prepared in 
dimethyl sulfoxide, the final concentrations being 
5 PM and 162 nM, respectively. Insulin release in 
the media was determined by radioimmunoassay 
using rat insulin as standard. Statistical 
significance was assessed by Student’s t-test for un- 
paired data. 
3. RESULTS AND DISCUSSION 
Digitonin is known to form pores which make 
the membrane freely permeable to inorganic ions 
by interacting with cholesterol in the cholesterol- 
rich plasma membrane, while it does not affect 
membranes which contain negligible amounts of 
cholesterol such as those of intracellular organelles 
[8]. The islets thus permeabilized with digitonin 
were incubated with Ca-EGTA buffers to give ar- 
bitrary concentrations of free Ca’+. Since the total 
calcium content of an islet was reported to be 
4.7 pmol on average [1], even the maximal con- 
tribution of mobilized Ca2+ from the intracellular 
organelles to [Ca’+]r should be nullified with a suf- 
ficient amount of EGTA (1 mM) in the buffer. 
Insulin release from digitonin-treated islets was 
stimulated by Ca2+ in a concentration-dependent 
manner, and the threshold was between 0.1 and 
1 PM (fig.l), which is similar to the results ob- 
tained from digitonin-treated chromaffin cells [9], 
or those from permeabilized islets by electric 
discharge [lo]. Colchicine (1 mM) inhibited insulin 
release induced by 10 FM Ca2+ by 36%, suggesting 
that the microtubular system is operating in the 
treated islets. 
A rise in the cyclic AMP content of islets is 
known to enhance insulin release when the islets 
are exposed to suitable secretagogues. The 
mechanism of the enhancement has been con- 
sidered to mobilize intracellular stored calcium, 
leading to an increase in (Ca2+]r, since cyclic AMP 
or agents that raise intracellular cyclic AMP levels 
increased 45Ca2+ efflux from pancreatic islets 
preloaded with the isotope [l]. However, a recent 
finding using a fluorescent Ca2+ indicator revealed 
that cyclic AMP stimulation of insulin release was 
not accompanied by increased [Ca2+]i [5]. Thus, 
the interpretation of the results derived from 
45Ca2+ flux studies is still a matter for debate. Our 
present data, in support of the results using the 
Ca2+ indicator, showed that 5 PM forskolin 
1 . 
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Fig. 1. Dependence of insulin release from digitonin- 
treated pancreatic slets upon Ca2’. Values are means k
SE (represented by bars), for the numbers of 
experiments shown in parentheses. Significance l vels: 
* p < 0.01, ** p < 0.001, vs the value at 0.01 /IM Ca’+. 
Table 1 
Effects of forskolin and TPA on insulin release from 
digitonin-treated pancreatic islets at various 
concentrations of Ca2+ 
[Ca”] 
W) 
Additions Insulin release 
(ng/5 islets per 30 min) 
0.01 none 0.48 f 0.03 (14) 
forskolin 0.58 f 0.04 (15) 
TPA 1.34 zrz 0.13b (16) 
0.1 none 0.72 f 0.15 (9) 
forskolin 1.03 f 0.12 (8) 
TPA 2.00 * O.Hb (9) 
1 none 1.09 * 0.09 (7) 
forskolin 1.54 + O.lla (7) 
TPA 4.53 I!I 0.41b (7) 
10 none 3.60 + 0.25 (13) 
forskolin 4.89 + 0.29’ (7) 
TPA 9.94 + 0.49b (16) 
Values are means f SE for the numbers of experiments 
shown in parentheses. Significance levels: a p < 0.01, 
b p < 0.001, vs control without addition 
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significantly augmented insulin release at 1 or 
10 PM Ca*+, as shown in table 1. The findings that 
forskolin did not significantly stimulate insulin 
release at lower concentrations of Ca*+, 0.01 and 
0.1 ,uM, are reminiscent of those in intact islets 
that the effects of cyclic AMP are usually small at 
low, non-stimulatory glucose concentrations [l]. 
Although the underlying mechanism(s) of the 
potentiation is not yet clear, one of the possibilities 
may be that cyclic AMP sensitizes the secretory 
machinery of pancreatic B cells to Ca*+, in analogy 
with the view on the role of cyclic nucleotides in 
platelet secretion [ 111. 
Growing attention has been paid to the involve- 
ment of protein kinase C in a wide variety of 
cellular functions, including insulin release. TPA is 
known to substitute for diacylglycerol and increase 
the affinity of protein kinase C for Ca*+ resulting 
in its activation without elevating [Ca*+]i [12]. As 
shown in table 1, addition of 162 nM TPA caused 
a significant insulin release at 0.01 and 0.1 ,KM 
Ca*+, and augmented that induced by 1 or 10 PM 
Ca*+. These data indicate that the phorbol ester 
modulates insulin release by a mechanism indepen- 
dent of a rise in [Ca”],. It was reported that TPA 
stimulated catecholamine release from adrenal 
medullary cells made leaky by exposure to an in- 
tense electric field [ 131. TPA was also shown in 
human platelets to evoke secretion and aggregation 
without elevating [Ca*+]i using a fluorescent Ca*+ 
indicator [14]. Taken together, it seems likely that 
activation of protein kinase C can modulate insulin 
release without a concomitant rise in [Ca*+]i. Two 
points should be noted. First, the results obtained 
under the present conditions do not rule out the 
possible involvement of mobilization of stored 
calcium in insulin release stimulated by TPA, as 
was suggested in [15] based on the data derived 
from 45Ca2+ efflux study, although 45Ca2+ efflux 
may not necessarily reflect [Ca*+]r, as mentioned 
above. Second, the effect of TPA on insulin 
release observed at 0.01 PM Ca*+ may not be 
mediated via activation of protein kinase C, but 
may rather be attributable to some other action(s) 
of TPA, since protein kinase C is reported to be 
hardly activated at Ca*+ concentrations below 
0.1 PM [12]. 
Our data lend support to the view that cyclic 
AMP modulates insulin release independently of 
changes of [Ca*+]i and also provide the first 
evidence that TPA, probably via protein kinase C, 
can stimulate insulin release without a rise in 
[Ca*+]i. 
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